Jefferies Group LLC Amicus Therapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2020 Sep 21, 2023	BUY	$13.47 - $24.89 $526,677 - $973,199	39,100 New	39,100 $902,000
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $431,815 - $532,315	33,500 Added 598.21%	39,100 $552,000
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $1.36 Million - $2.29 Million	-205,000 Reduced 97.34%	5,600 $52,000
Q4 2019 Feb 13, 2020	BUY	$7.48 - $10.75 $1.58 Million - $2.26 Million	210,600 New	210,600 $2.05 Million
Q3 2019 Nov 13, 2019	SELL	$8.02 - $13.25 $1.6 Million - $2.65 Million	-200,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$10.96 - $14.4 $2.19 Million - $2.88 Million	200,000 New	200,000 $2.5 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.